Clinical Trials Browser

Phase 2 × Immunoglobulin Light-chain Amyloidosis × isatuximab × Clear all

Lymphadenopathy, Immunoglobulin Light-chain Amyloidosis, Constipation, Diarrhea, Gastrointestinal Hemorrhage, Hepatomegaly, Macroglossia, Nausea, Purpura

NCT05066607 2024-03-06

IsAMYP

Phase 2 Unknown

46 enrolled

Plasma cell

Immunoglobulin Light-chain Amyloidosis, Amyloidosis

Clinical Trials

S1702 Isatuximab in Treating Patients With Relapsed or Refractory Primary Amyloidosis

IsAMYP